285 related articles for article (PubMed ID: 17038677)
1. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity.
Morais CG; Soares IS; Carvalho LH; Fontes CJ; Krettli AU; Braga EM
Am J Trop Med Hyg; 2006 Oct; 75(4):582-7. PubMed ID: 17038677
[TBL] [Abstract][Full Text] [Related]
2. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
3. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
5. Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Premaratne PH; Perera KL; Bandara S; Kocken CH; Thomas AW; Handunnetti SM; Udagama-Randeniya PV
Infect Immun; 2006 Jan; 74(1):798-801. PubMed ID: 16369044
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
8. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
[TBL] [Abstract][Full Text] [Related]
9. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection.
Múfalo BC; Gentil F; Bargieri DY; Costa FT; Rodrigues MM; Soares IS
Microbes Infect; 2008 Oct; 10(12-13):1266-73. PubMed ID: 18692152
[TBL] [Abstract][Full Text] [Related]
12. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
[TBL] [Abstract][Full Text] [Related]
13. Malaria epidemiology in low-endemicity areas of the Atlantic Forest in the Vale do Ribeira, São Paulo, Brazil.
Curado I; Dos Santos Malafronte R; de Castro Duarte AM; Kirchgatter K; Branquinho MS; Bianchi Galati EA
Acta Trop; 2006 Nov; 100(1-2):54-62. PubMed ID: 17126279
[TBL] [Abstract][Full Text] [Related]
14. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region.
Kano FS; Sanchez BA; Sousa TN; Tang ML; Saliba J; Oliveira FM; Nogueira PA; Gonçalves AQ; Fontes CJ; Soares IS; Brito CF; Rocha RS; Carvalho LH
Trop Med Int Health; 2012 Aug; 17(8):989-1000. PubMed ID: 22643072
[TBL] [Abstract][Full Text] [Related]
17. Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon.
Cerávolo IP; Bruña-Romero O; Braga EM; Fontes CJ; Brito CF; Souza JM; Krettli AU; Adams JH; Carvalho LH
Am J Trop Med Hyg; 2005 Jun; 72(6):675-81. PubMed ID: 15964949
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon.
Furini AA; Capobianco MP; Storti-Melo LM; Cunha MG; Cassiano GC; Machado RL
Malar J; 2016 Jul; 15(1):374. PubMed ID: 27435973
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.
Dias S; Somarathna M; Manamperi A; Escalante AA; Gunasekera AM; Udagama PV
Vaccine; 2011 Oct; 29(43):7491-504. PubMed ID: 21784116
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax: immune responses in a cross-section of the population in the Delhi area of India.
Ray P; Ansari MA; Sharma YD
Am J Trop Med Hyg; 1994 Oct; 51(4):436-43. PubMed ID: 7943570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
